within Pharmacolibrary.Drugs.ATC.S;

model S03CA06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.05,
    Cl             = 0.1 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,
    adminCount     = 1,
    Vd             = 0.0015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Combination drug containing betamethasone, a potent synthetic glucocorticoid corticosteroid with anti-inflammatory and immunosuppressive properties, and antiinfectives, typically for topical ophthalmic use to treat eye infections with an inflammatory component. Not widely approved as a fixed combination in all regions today, but used in some countries.</p><h4>Pharmacokinetics</h4><p>No published population pharmacokinetic studies of the fixed combination of betamethasone with antiinfectives (S03CA06) have been identified. Pharmacokinetic parameters estimated based on topical ophthalmic betamethasone data in healthy adults.</p><h4>References</h4><ol><li><p>Molesini, S, et al., &amp; Vertuani, S (2018). Influences of the vehicle in the spreading and release of betamethasone. <i>Therapeutic delivery</i> 9(3) 177–184. DOI:<a href=&quot;https://doi.org/10.4155/tde-2017-0070&quot;>10.4155/tde-2017-0070</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29424289/&quot;>https://pubmed.ncbi.nlm.nih.gov/29424289</a></p></li><li><p>Leal, LB, et al., &amp; Guy, RH (2017). Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug. <i>Pharmaceutical research</i> 34(4) 730–737. DOI:<a href=&quot;https://doi.org/10.1007/s11095-017-2099-1&quot;>10.1007/s11095-017-2099-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28097506/&quot;>https://pubmed.ncbi.nlm.nih.gov/28097506</a></p></li><li><p>Zulfakar, MH, et al., &amp; Heard, CM (2010). Enhanced topical delivery and ex vivo anti-inflammatory activity from a betamethasone dipropionate formulation containing fish oil. <i>Inflammation research : official journal of the European Histamine Research Society ... [et al.]</i> 59(1) 23–30. DOI:<a href=&quot;https://doi.org/10.1007/s00011-009-0065-z&quot;>10.1007/s00011-009-0065-z</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19644736/&quot;>https://pubmed.ncbi.nlm.nih.gov/19644736</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S03CA06;
